⌘K

Login Start Free

Home/Filings/4/0000875320-24-000107

4//SEC Filing

Sachdev Amit 4

Accession 0000875320-24-000107

CIK 0000875320other

View on SEC.gov Company Profile

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 4:59 PM ET

Size

7.5 KB

Accession

0000875320-24-000107

Insider Transaction Report

Form 4

Period: 2024-02-23

VERTEX PHARMACEUTICALS INC / MAVRTX

EVP Chief Patient & Ext Af Off

Transactions

Tax Payment
Common Stock
2024-02-23$431.79/sh−2,469$1,066,090→ 58,329 total
Sale
Common Stock
2024-02-26$425.70/sh−3,004$1,278,803→ 55,325 total

Holdings

Common Stock
(indirect: By 401(k))
882
Common Stock
(indirect: By Trust)
6,565

Footnotes (1)

[F1]Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2023.

Documents

1 file

4
wk-form4_1709071114.xmlPrimary
FORM 4

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001406338

Filing Metadata

Form type: 4
Filed: Feb 26, 7:00 PM ET
Accepted: Feb 27, 4:59 PM ET
Size: 7.5 KB

View on SEC.gov